Supriya Lifescience Shares Surge Over 16 After Strong Q4FY26 Results PAT Up 47 Revenue Jumps 50 COLL Q1 2026 Earnings EPS Surges Past Estimates Despite Modest Stock Pullback US Q1 GDP Growth Revised Down to 16 Missing Expectations